Embolization therapy is the minimally invasive procedure where an embolus is administered for stopping the bleeding or for cutting off the blood supply to a tumor, to shrink it and prepare for its removal. Several interventional radiology procedures uses Embolization, where the interventional radiologist makes use of a image guidance for inserting the catheter within the primary artery, advancing it to the vessel that leads to the tumor or several parts where the supply of blood needs to be stopped. Embolization is the alternative for certain patients having tumors which cannot be surgically removed. The process is used for treating different types of hemorrhages, cancerous tumors, along with managing malignant hypertension resulted due to renal failure.
The procedure of Embolization uses several embolization particle types including radioembolization spheres, gelfoam particles, drug eluting beads, microspheres, PVA particles, and others. The particles are utilized in various procedures including liver cancer, kidney cancer, metastatic cancer within liver, neuroendocrine tumors, aneurysms and uterine fibroids. The particles are majorly used treat various cancer types whose global prevalence has been constantly increasing.
Global Embolization Particle Market – Market Dynamics
Increasing cancer prevalence around the world, is expected to drive the global embolization particle market growth. As per the World Health Organization (WHO), globally cancer accounts for the second major cause of mortality, with over 9.6 Mn cancer caused deaths in 2018. Furthermore, according to the Cancer Research UK, around 17 Mn new cancer cases were projected to cause, in 2018 globally. The cancer burden is rapidly increasing within the U.S., with prevalence of 439.2 /100,000 women and men every year, as per the National Cancer Institute, in 2015.
Furthermore, major companies are constantly launching advanced technology products having improved efficiency, which in turn, is expected to fuel the global embolization particle market growth over the forecast period. For instance, Sirtex, in 2017, launched SIR-Spheres Y-90 resin microspheres that serves as the first-line treatment for liver metastases patients with right-sided primary colon cancer. The UK National Institute for Health and Care Excellence (NICE), in 2016, issued a latest update expressing that commissioners and doctors from National Health Service (NHS), may think of Sirtex’s SIR-Spheres Y-90 resin microspheres as a standard therapy alternative with sorafenib or trans-arterial chemoembolization (TACE) to treat patients suffering primary liver cancer that is inoperable.
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2374
However, less number of interventional neuroradiology (INR) labs and interventional neuroradiologists globally along with stringent regulations for the approvals of embolization particle are some major factors expected to hamper the global embolization particle market growth over the forecast period.
Global Embolization Particle Market – Regional Insights
Based on region, the global embolization particle market is segregated into North America, Europe Latin America, Asia Pacific, Africa, and Middle East. North America is expected to hold a dominant position, in 2017, in the global embolization particle market, owing to strong economic conditions, healthcare domain’s huge expansion, and research institutions increasingly focusing on developing technology for advanced, novel treatment and diagnosis methods. Moreover, novel hospital infrastructures, along with presence of qualified healthcare professionals, is driving the global embolization particle market growth.
Furthermore, Asia Pacific region is expected to register robust growth in the global embolization particle market over the forecast period, due to rising prevalence of patients (mainly cancer) within emerging economies including India. For instance, as per the Indian Council Medical Research (ICMR), over 1.73 Mn new cases of cancer and over 880,000 cancer deaths are expected to be registered in India, by 2020. Furthermore, government is increasingly focusing on improving healthcare facilities along with growing medical tourism, which is expected to propel the global embolization particle market growth within the region.
Global Embolization Particle Market – Competitive Landscape
Key players functioning in the global embolization particle market are, Abbott Laboratories, BTG plc, Boston Scientific Corporation, Cook Medical, Inc., Johnson & Johnson, Edwards Lifesciences, Pfizer, Inc., Terumo Corporation, Sirtex Medical Limited, and St. Jude Medical, Inc.
Major players are focused on acquisitions and mergers and novel product launches for retaining a dominant market position. For instance, Boston Scientific, in November 2018, declared its plans of acquiring BTG plc – a global interventional medicine’s healthcare company. This would support the company for developing and commercializing products used to target vascular diseases and cancer though procedures that are minimally-invasive.
Global Embolization Particle Market Taxonomy
Based on product type,
- Radioembolization Spheres
- Drug-Eluting Beads
- PVA Particles & Gelfoam Particles
- Other Particles
Based on application,
- Peripheral Vascular Disease
Based on end-user,
- Ambulatory Centers
- Hospitals & Clinics
Based on treatment,
- Direct Vision Internal Urethrotomy (DVIU)
- Urethral Dilation
Based on geography,
- North America
- Latin America
- Asia Pacific
- Middle East
Main points in Embolization Particle Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Embolization Particle Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Embolization Particle Industry Impact
Chapter 2 Global Embolization Particle Competition by Types, Applications, and Top Regions and Countries
2.1 Global Embolization Particle (Volume and Value) by Type
2.3 Global Embolization Particle (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Embolization Particle Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Embolization Particle Market Analysis
Chapter 6 East Asia Embolization Particle Market Analysis
Chapter 7 Europe Embolization Particle Market Analysis
Chapter 8 South Asia Embolization Particle Market Analysis
Chapter 9 Southeast Asia Embolization Particle Market Analysis
Chapter 10 Middle East Embolization Particle Market Analysis
Chapter 11 Africa Embolization Particle Market Analysis
Chapter 12 Oceania Embolization Particle Market Analysis
Chapter 13 South America Embolization Particle Market Analysis
Chapter 14 Company Profiles and Key Figures in Embolization Particle Business
Chapter 15 Global Embolization Particle Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027